Protocol – summary

'Many thanks to all of the teams involved for your great work! ...we wish to express our gratitude to all sites making great efforts to look for patients in the IgY-study. We have experienced such motivation from all the investigators and study coordinators and everyone involved that we are very confident that the chart will change a lot in the near future.'

-  Newsletter PsAer-IgY 1. Quarter 2013

The study is a prospective randomized, placebo-controlled, double blind, multicenter study (phase III) to evaluate clinical efficacy and safety of avian polyclonal anti-Pseudomonas antibodies (IgY) in prevention of recurrence of Pseudomonas aeruginosa infection in cystic fibrosis patients.

Download the study synopsis (pdf).